4.3 Article

Novel Clinician-Lead Intervention to Address Fear of Cancer Recurrence in Breast Cancer Survivors

Journal

JCO ONCOLOGY PRACTICE
Volume 17, Issue 6, Pages 351-E784

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1200/OP.20.00799

Keywords

-

Categories

Funding

  1. Sydney Breast Cancer Foundation
  2. AVANT Foundation

Ask authors/readers for more resources

The brief oncologist-delivered intervention is shown to be effective in reducing the severity of fear of cancer recurrence and well-received by participants.
PURPOSE: Fear of cancer recurrence (FCR) affects 50%-70% of cancer survivors. This multicenter, single-arm study sought to determine the participant-rated usefulness of an oncologist-delivered FCR intervention. METHODS: Women who completed treatment for early breast cancer (could be receiving endocrine therapy) with baseline FCR > 0 were invited to participate. FCR was measured using a validated 42-item FCR Inventory. The brief oncologist-delivered intervention entailed (1) FCR normalization; (2) provision of personalized prognostic information; (3) recurrence symptoms education, (4) advice on managing worry, and (5) referral to psycho-oncologist if FCR was high. FCR, depression, and anxiety were assessed preintervention (T0), at 1 week (T1), and 3 months (T2) postintervention. The primary outcome was participant-rated usefulness. Secondary outcomes included feasibility and efficacy. RESULTS: Five oncologists delivered the intervention to 61/255 women invited. Mean age was 58 +/- 12 years. Mean time since breast cancer diagnosis was 2.5 +/- 1.3 years. Forty-three women (71%) were on adjuvant endocrine therapy. Of 58 women who completed T1 assessment, 56 (97%) found the intervention to be useful. FCR severity decreased significantly at T1 (F = 18.5, effect size = 0.39, P < .0001) and T2 (F = 24, effect size = 0.68, P < .0001) compared with baseline. There were no changes in unmet need or depression or anxiety. Mean consultation length was 22 minutes (range, 7-47 minutes), and mean intervention length was 8 minutes (range, 2-20 minutes). The intervention was perceived as useful and feasible by oncologists. CONCLUSION: A brief oncologist-delivered intervention to address FCR is useful and feasible, and has preliminary efficacy in reducing FCR. Plans for a cluster randomized trial are underway.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Oncology

Experiences and perspectives of cancer stakeholders regarding COVID-19 vaccination

Nicci Bartley, Polly Havard, Phyllis Butow, Joanne Shaw

Summary: This study aimed to explore the perspectives of cancer stakeholders regarding COVID-19 vaccination. The findings revealed mostly positive attitudes towards the vaccine, but also highlighted concerns, hesitancy, and uncertainty. Policymakers need to provide clear tailored information to facilitate vaccine uptake.

ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY (2023)

Article Medicine, General & Internal

Exploring assessment of balance using virtual reality in patients at risk of chemotherapy-induced peripheral neuropathy

Christina Teng, Elodie Chiarovano, David Tighe, Kim Tam Bui, Venkatesha, Prunella L. Blinman, Hamish G. MacDougall, Janette L. Vardy

Summary: This study aimed to assess the impact of potentially neurotoxic chemotherapy on balance using virtual reality (VR) technology, and explore associations between VR balance assessment, falls, and chemotherapy-induced peripheral neuropathy (CIPN). The results showed that VR balance assessment was not better at identifying CIPN than existing measures, but it can serve as a potential surrogate method to assess patients at risk of falls from CIPN.

INTERNAL MEDICINE JOURNAL (2023)

Article Oncology

Healthcare experiences of people with advanced colorectal cancer: A qualitative study

Chloe Yi Shing Lim, Rebekah C. Laidsaar-Powell, Jane M. Young, Daniel Steffens, Nabila Ansari, Grace Joshy, Phyllis Butow, Adv CRC Survivorship Authorship Grp

Summary: This study fills a gap in qualitative research regarding the healthcare experiences and needs of people with advanced colorectal cancer (CRC-A) through interviews with 38 participants. The study identifies six key themes relating to the safety, effectiveness, timeliness, patient-centeredness, efficiency, and equity of CRC-A care. The findings highlight the importance of delivering repeated information, upskilling general practitioners, and implementing survivorship care plans or clinics to improve the healthcare system for CRC-A.

EUROPEAN JOURNAL OF ONCOLOGY NURSING (2023)

Review Oncology

Caregiver fear of cancer recurrence: A systematic review and meta-analysis of quantitative studies

Kyra Webb, Louise Sharpe, Phyllis Butow, Haryana Dhillon, Robert Zachariae, Nina Moller Tauber, Mia Skytte O'Toole, Joanne Shaw

Summary: This study compared the levels of fear of cancer recurrence (FCR) between cancer survivors and caregivers through a meta-analysis. It also examined the relationship between caregiver FCR, depression, and anxiety, and evaluated the psychometric properties of caregiver FCR measures. The results showed that caregivers reported FCR levels similar to survivors, with around 48% of caregivers reporting clinically significant FCR levels. There was a strong correlation between anxiety and depression and medium correlation with survivor FCR. The existing measurement tools for caregiver FCR mostly relied on survivor conceptualizations and lacked validation.

PSYCHO-ONCOLOGY (2023)

Review Psychiatry

Differentiating melancholic and non-melancholic depression via biological markers: A review

Michael J. Spoelma, Anastasia Serafimovska, Gordon Parker

Summary: The objective of this paper was to review potential biomarkers of melancholia in order to improve differential diagnosis, clinical response, and treatment outcomes. By comparing melancholic with non-melancholic depression, we emphasized the importance of distinguishing melancholia as its own condition.

WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2023)

Article Education & Educational Research

Protocol of an implementation study of a clinician intervention to reduce fear of recurrence in cancer survivors (CIFeR_2 implementation study)

Jia Liu, Anastasia Serafimovska, Sharon He, Phyllis Butow, Joanne Shaw, Christopher John McHardy, Georgia Harris, Zoe Butt, Jane Beith

Summary: The study aims to explore the barriers and facilitators to implementing a low-cost brief intervention (CIFeR) to reduce fear of cancer recurrence (FCR) in routine oncology practice in Australia. The primary objective is to assess the adoption of CIFeR in routine clinical practice, while secondary objectives include identifying the uptake and sustainability, acceptability, feasibility, costs, barriers, and facilitators of CIFeR implementation, as well as assessing the impact of CIFeR training on clinicians' self-efficacy in managing FCR.

BMC MEDICAL EDUCATION (2023)

Review Oncology

Psychosocial experiences of breast cancer survivors: a meta-review

R. King, L. Stafford, P. Butow, S. Giunta, R. Laidsaar-Powell

Summary: This meta-review examines the qualitative evidence-base on breast cancer survivorship experiences and identifies the main themes and areas for further investigation.

JOURNAL OF CANCER SURVIVORSHIP (2023)

Article Oncology

Scanxiety Conversations on Twitter: Observational Study

Kim Tam Bui, Zoe Li, Haryana M. Dhillon, Belinda E. Kiely, Prunella Blinman

Summary: This study analyzed posts on Twitter related to scanxiety and found that it is a common negative experience among cancer patients. The study also described the demographics of users posting about scanxiety. The findings contribute to a better understanding of scanxiety and highlight the importance of reducing it.

JMIR CANCER (2023)

Article Public, Environmental & Occupational Health

Family communication and results disclosure after germline sequencing: A mixed methods study

Camelia Harrison, Nicci Bartley, Chris Jacobs, Megan Best, Sabina Vatter, Bettina Meiser, Mandy L. Ballinger, David M. Thomas, Phyllis Butow

Summary: This study aimed to explore cancer patients' perceived importance of disclosure, predictors of perceptions, and perspectives on family communication of germline genome sequencing results. The results showed that most participants intended to disclose results to their nuclear family, considered the results as family information, and believed it was important to disclose results to family members. Education level and the level of communication within the nuclear and extended family were significantly positively associated with the perceived importance of disclosure. Low health literacy and family conflict can complicate the communication of germline genome sequencing results.

PATIENT EDUCATION AND COUNSELING (2023)

Article Oncology

ConquerFear-Group: A randomized controlled trial of an online-delivered group-based psychological intervention for fear of cancer recurrence in breast cancer survivors

Nina M. M. Tauber, Mia S. S. O'Toole, Anders B. B. Jensen, Phyllis N. N. Butow, Belinda Thewes, Emma Elkjaer, Sofie Knutzen, Annika von Heymann, Christoffer Johansen, Robert Zachariae

Summary: This randomized controlled trial evaluated the efficacy of an online group-based psychological intervention (ConquerFear-Group) for fear of cancer recurrence (FCR). The results showed that ConquerFear-Group significantly reduced the severity of FCR and maintained stable effects over a 6-month period.

PSYCHO-ONCOLOGY (2023)

Article Oncology

Application of a revised model for coping with advanced cancer to qualitatively explore lung cancer survivors' experiences of ongoing physical effects, novel treatments, uncertainty, and coping

Rebekah Laidsaar-Powell, Phyllis Butow, Bernadette Bea Brown, Kimberley Mander, Jane Young, Emily Stone, Venessa Chin, Emily Banks, Chloe Yi Shing Lim, Nicole M. Rankin

Summary: This study aimed to understand lung cancer survivors' physical/psychological challenges, experiences of immunotherapy and targeted therapy, and psychological adjustment. The findings showed that many survivors are adapting to issues as they arise and maintaining a sense of hope and optimism.

JOURNAL OF CANCER SURVIVORSHIP (2023)

Meeting Abstract Respiratory System

Carrying on with life as a lung cancer survivor: Qualitative insights on survivors' employment, finances, relationships, and healthcare experiences

Rebekah Laidsaar-Powell, Phyllis Butow, Bea Brown, Kimberley Mander, Jane Young, Emily Stone, Venessa Chin, Emily Banks, Nicole Rankin

RESPIROLOGY (2023)

Meeting Abstract Respiratory System

Coping and adjustment to lung cancer in the immunotherapy and targeted therapies era: Experiences of Australian lung cancer survivors

Rebekah Laidsaar-Powell, Phyllis Butow, Bea Brown, Kimberley Mander, Jane Young, Emily Stone, Venessa Chin, Emily Banks, Chloe Lim, Nicole Rankin

RESPIROLOGY (2023)

Article Oncology

A novel clinician-delivered intervention to reduce fear of recurrence in breast cancer survivors: Results from a Phase I/II implementation study (CIFeR_2)

Jia Liu, Sharon He, Phyllis Butow, Joanne Shaw, Christopher John Mchardy, Georgia Harris, Anastasia Serafimovska, Zoe Butt, Jane Beith

Summary: A novel brief clinician intervention, CIFeR, aimed at reducing fear of cancer recurrence in breast cancer patients has been shown to be feasible, acceptable, and effective in improving self-efficacy in managing FCR. The intervention was adopted by 82% of participating clinicians, with self-efficacy significantly improving across all domains. Lack of time was identified as the main barrier to routine implementation of CIFeR.

PSYCHO-ONCOLOGY (2023)

Article Dermatology

Epidermal growth factor receptor inhibitors in advanced cutaneous squamous cell carcinoma: A systematic review and meta-analysis

James P. Pham, Anthony Rodrigues, Simone M. Goldinger, Hao-Wen Sim, Jia Liu

Summary: EGFR inhibitors may be a treatment option for patients with advanced cSCC who are ineligible for or fail to respond to anti-PD1 immunotherapy. This systematic review and meta-analysis found that EGFR inhibitors had a moderate objective response rate and median survival in these patients, but also had a high rate of adverse events.

EXPERIMENTAL DERMATOLOGY (2023)

No Data Available